{"id":95755,"date":"2018-10-22T13:02:53","date_gmt":"2018-10-22T13:02:53","guid":{"rendered":"http:\/\/www.bnreport.com\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/"},"modified":"2018-10-22T13:02:53","modified_gmt":"2018-10-22T13:02:53","slug":"buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi","status":"publish","type":"post","link":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/","title":{"rendered":"Buy  Sun Pharmaceutical Industries, target Rs  655:   Gaurav Ratnaparkhi"},"content":{"rendered":"<p><a href=\"https:\/\/economictimes.indiatimes.com\/topic\/Gaurav-Ratnaparkhi\" rel=\"noreferrer\" target=\"_blank\">Gaurav Ratnaparkhi<\/a> of Sharekhan has a buy call on Sun Pharmaceutical Industries with a target price of Rs 655. <\/p>\n<p>The current market price of Sun Pharmaceutical Industries is Rs 613.50. <\/p>\n<p>Time period given by the analyst is two weeks when Sun Pharmaceutical Industries price can reach the defined target.  <\/p>\n<p>Gaurav Ratnaparkhi recommended keeping a stop loss at Rs 588. <\/p>\n<p>&quot;The stock has been trading in sideways manner for last couple of weeks. As a result it has formed a bullish Inside bar on the weekly chart. On the downside, the stock is getting support near its crucial weekly moving averages. Thus the stock seems to be preparing for a sharp bounce back. The hourly &amp; daily momentum indicators have given fresh buy signals. Hence, the stock can head towards its daily &amp; weekly upper Bollinger Bands,&quot; Ratnaparkhi said. <\/p>\n<p>Sun Pharmaceutical Industries, incorporated in the year 1993, is a large-cap company (having a market cap of Rs 1,45,974.91 crore) operating in Pharmaceuticals and health care sector.  <\/p>\n<p>The companys top management includes Mr.Ashwin Dani, Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Keki M Mistry, Mr.S Mohanchand Dadha, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi.  <\/p>\n<p>The company has S R B C &amp; Co. LLP as its auditors.  <\/p>\n<p>As on 30-06-2018, the company has a total of 2,399,324,494 shares outstanding. <\/p>\n<p><strong><a href=\"https:\/\/blockads.fivefilters.org\/\" rel=\"noreferrer\" target=\"_blank\"><\/a><\/strong> <a href=\"https:\/\/blockads.fivefilters.org\/acceptable.html\" rel=\"noreferrer\" target=\"_blank\"><\/a><\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/recos\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/articleshow\/66311382.cms\" rel=\"noreferrer\" target=\"_blank\">Original Article<\/a><\/p>\n<p>[contf]<br \/>\n[contfnew]<br \/>\n        <img decoding=\"async\" src=\"https:\/\/img.etimg.com\/photo\/60278104.cms\"\/><\/p>\n<h5><a href=\"https:\/\/economictimes.indiatimes.com\/\" rel=\"noreferrer\" target=\"_blank\">ET Markets<\/a><\/h5>\n<p>[contfnewc]<br \/>\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..<\/p>\n","protected":false},"author":1,"featured_media":95756,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[202],"tags":[],"class_list":["post-95755","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Buy Sun Pharmaceutical Industries, target Rs 655:  Gaurav Ratnaparkhi - Business News Report<\/title>\n<meta name=\"description\" content=\"Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buy Sun Pharmaceutical Industries, target Rs 655:  Gaurav Ratnaparkhi - Business News Report\" \/>\n<meta property=\"og:description\" content=\"Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-22T13:02:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/10\/photo-8-11.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1070\" \/>\n\t<meta property=\"og:image:height\" content=\"580\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav Ratnaparkhi\",\"datePublished\":\"2018-10-22T13:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/\"},\"wordCount\":247,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/photo-8-11.jpg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/\",\"name\":\"Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav Ratnaparkhi - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/photo-8-11.jpg\",\"datePublished\":\"2018-10-22T13:02:53+00:00\",\"description\":\"Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/photo-8-11.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/photo-8-11.jpg\",\"width\":1070,\"height\":580},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav Ratnaparkhi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics &amp; Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Buy Sun Pharmaceutical Industries, target Rs 655:  Gaurav Ratnaparkhi - Business News Report","description":"Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/","og_locale":"en_US","og_type":"article","og_title":"Buy Sun Pharmaceutical Industries, target Rs 655:  Gaurav Ratnaparkhi - Business News Report","og_description":"Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..","og_url":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2018-10-22T13:02:53+00:00","og_image":[{"width":1070,"height":580,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/10\/photo-8-11.jpg","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav Ratnaparkhi","datePublished":"2018-10-22T13:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/"},"wordCount":247,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/10\/photo-8-11.jpg","articleSection":["Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/","url":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/","name":"Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav Ratnaparkhi - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/10\/photo-8-11.jpg","datePublished":"2018-10-22T13:02:53+00:00","description":"Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharma..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/10\/photo-8-11.jpg","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/10\/photo-8-11.jpg","width":1070,"height":580},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/buy-sun-pharmaceutical-industries-target-rs-655-gaurav-ratnaparkhi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav Ratnaparkhi"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics &amp; Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/95755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=95755"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/95755\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/95756"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=95755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=95755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=95755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}